Sample size re-estimation: Recent developments and practical considerations

Statistics in Medicine

Volumn 20, Issue 17-18, 2001, Pages 2625-2643

  Lawrence Gould, A ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTICAL ERROR; ARTICLE; CLINICAL RESEARCH; CLINICAL TRIAL; CONTROL SYSTEM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; FOLLOW UP; HUMAN; HYPOTHESIS; INFORMATION PROCESSING; MATHEMATICAL ANALYSIS; MEDICAL CARE; METHODOLOGY; PATIENT CARE; PILOT STUDY; PRACTICE GUIDELINE; SAMPLING; SIMULATION; STATISTICAL ANALYSIS; STATISTICAL CONCEPTS;

CLINICAL TRIALS; COMPUTER SIMULATION; HUMANS; PATIENT SELECTION; SAMPLE SIZE;

EID: 0035884237     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/sim.733     Document Type: Article

References (48)

1. Approximately optimal one-parameter boundaries for group sequential trials
2. A multiple testing procedure for clinical trials
3. Planning and revising the sample size for a trial
4. Elicitation of prior distributions
5. Methodological problems in the retrospective computation of responsiveness to change: The lesson of Cronbach
6. Interpreting treatment effects in randomised trials
7. On the use of the upper confidence limit for the variance from a pilot sample for sample size determination
8. Confidence intervals for power with special reference to medical trials
9. Applications of interval inference
10. Sample sizes required for binomial trials when the true response rates are estimated
11. Semiparametric efficiency and its implication on the design and analysis of group-sequential studies
12. A two-sample test for a linear hypothesis whose power is independent of the variance
13. The role of internal pilot studies in increasing the efficiency of clinical trials (with comments)
14. Internal pilot-studies for estimating sample-size
15. A method for determining the size of internal pilot-studies
16. Internal pilot studies I: Type I error rate of the naive t-test
17. Group Sequential Methods with Applications to Clinical Trials
18. Estimating the sample size for a t-test using an internal pilot
19. Accurate multivariate estimation using triple sampling
20. An examination of methods for sample size recalculation during an experiment
21. Sequential estimation
22. Second order approximations for sequential point and interval estimation
23. The use of interim analysis for sample size adjustment
24. Biostatistical methodology in clinical trials in applications for marketing authorizations for medicinal products
25. Statistical principles for clinical trials (ICH Harmonized Tripartite Guideline E-9)
26. Interim analyses for monitoring clinical trials that do not materially affect the type I error rate
27. Design for sample size re-estimation with interim data for double-blind clinical trials with binary outcomes
28. Sample size re-estimation without unblinding for normally distributed outcomes with unknown variance
29. Issues in blinded sample size re-estimation
30. Reevaluating design specifications of longitudinal clinical trials without unblinding when the key response is rate of change
31. Blinded sample size re-estimation with unequal variances and center effects in clinical trials
32. Modifying the design of ongoing trials without unblinding
33. Sample size review in a head injury trial with ordered categorical responses
34. Sample size calculations for ordered categorical data
35. Stochastic curtailing for comparison of slopes in longitudinal studies
36. Stochastically curtailed tests in long-term clinical trials
37. More flexible sequential and non-sequential designs in long-term clinical trials
38. Conditional power calculations as an aid in the decision whether to continue a clinical trial
39. Internally adaptive designs for parallel group trials
40. Estimation of parameters and sample size re-estimation
41. Modification of sample size in group sequential clinical trials
42. Designed extension of studies based on conditional power
43. Self-designing clinical trials
44. Internal pilot studies II: Comparison of various procedures
45. Discussion of impact of trial conduct change in clinical trials
46. Sequential monitoring of clinical trials: The role of information and Brownian motion
47. Data monitoring committees and problems of lower-than-expected accrual or event rates